Mavoglurant Effective Against Cocaine Addiction in Phase 2 Trial
The drug company, Novartis, reports a significant decline in cocaine use with mavoglurant in phase 2 trial.
Dr. Anna Lembke on Using GLP-1 Drugs to Treat Addiction
Stanford University psychiatrist, Dr. Anna Lembke, assesses the use of GLP-1 drugs for treating addictions.
More About the Unwanted Inheritance
The latest research confirms that epigenetic changes are involved in substance use disorders. It would not be surprising to find them accountable for most of what we characterize as addiction.
Music and Addiction
Music is capable of triggering substance abuse and also treating substance abuse.
Deep Brain Stimulation for Addiction Treatment
Two hospitals in England are teaming up to test the Brain-PACER deep brain stimulation treatment for substance use disorders.
Online Shopping Addiction and Compulsive Buying
Award-winning journalist, Emma Marris, travels the world following the science of shopping addiction and compulsive buying.